HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kini, R. M. Articles by Evans, H. J. Search for Related Content PubMed PubMed Citation Articles by Kini, R. M. Articles by Evans, H. J. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 262, Issue 30, 14402-14407, 10, 1987

Structure-function relationships of phospholipases. The anticoagulant region of phospholipases A2

RM Kini and HJ Evans
Department of Biochemistry, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.

In an effort to identify the anticoagulant region of venom phospholipases A2, we have systematically compared the amino acid sequences of strong, weak and non-anticoagulant phospholipases. The comparison disclosed several significant substitutions in the region between residues 54 and 77 (homology numbers). This proposed anticoagulant region is positively charged in strong, but negatively charged in weak and non-anticoagulant phospholipases. The microenvironment of a tryptophan residue falls within the proposed region, accounting for the differential characteristics of intrinsic fluorescence changes observed at 335 nm after the binding of phospholipid vesicles to strong and weak anticoagulants. Four lysine residues are located in specific positions in the "anticoagulant" region of strong anticoagulants, and should form a cationic surface, based on analogy with the available crystallographic structures. The chemical modification of lysine, arginine, tyrosine, and tryptophan residues and carboxylate groups, performed by other investigators, not only provides added support for the predicted site, but also confirms the essentiality of the positive charges in the site. This region may participate in the formation of a specific preferential hydrolytic complex leading to the strong anticoagulant effect. The anticoagulant region is distinct and separate from the predicted neurotoxic and myotoxic sites, and is located on the opposite surface of the phospholipase molecule.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. T. Wijewickrama, A. Albanese, Y. J. Kim, Y. S. Oh, P. S. Murray, R. Takayanagi, T. Tobe, S. Masuda, M. Murakami, I. Kudo, et al. Unique Membrane Interaction Mode of Group IIF Phospholipase A2 J. Biol. Chem., October 27, 2006; 281(43): 32741 - 32754. [Abstract] [Full Text] [PDF]

				T. M. Hackeng, J. H. Griffin, and P. E. Dawson Protein synthesis by native chemical ligation: Expanded scope by using straightforward methodology PNAS, August 31, 1999; 96(18): 10068 - 10073. [Abstract] [Full Text] [PDF]

				C. M. Mounier, T. M. Hackeng, F. Schaeffer, G. Faure, C. Bon, and J. H. Griffin Inhibition of Prothrombinase by Human Secretory Phospholipase A2 Involves Binding to Factor Xa J. Biol. Chem., September 11, 1998; 273(37): 23764 - 23772. [Abstract] [Full Text] [PDF]

				T. M. Hackeng, C. M. Mounier, C. Bon, P. E. Dawson, J. H. Griffin, and S. B. H. Kent Total chemical synthesis of enzymatically active human type II secretory phospholipase A2 PNAS, July 22, 1997; 94(15): 7845 - 7850. [Abstract] [Full Text] [PDF]